Accurate International
Latest round
- Series B
Last raised
- May 2025
Total raised
- $29M
Investors
- 3
About Accurate International
, Ltd develops and applies organoid technologies for use in cancer precision therapy, new drug development and regenerative medicine. The company operates across research, diagnosis and clinical application. Established in 2018 and based in Guangzhou, China, Accurate International has expanded its operations through three subsidiaries in Beijing, Shanghai and Macau. In 2022, the company launched its integrated platform for organoid-based R&D, diagnosis and personalized drug screening. The company's self-developed products include Peixinan, an organoid-targeted drug sensitivity assay, Peixinkang, an individualized tumor companion diagnostic combining organoid drug sensitivity technology with second-generation sequencing technology, and Accuroid™, an organ culture and organoid drug sensitivity screening product. Their products are used in the field of scientific research, drug development, clinical application and precision tumor therapy. The company generates revenue mainly through the sales of drugs and preclinical research services, clinical drug testing and collaborations with pharmaceutical and healthcare institutions.
Who invested in Accurate International
3 investors across 2 rounds
See all investors in Accurate International
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Accurate International
Who invested in Accurate International?
Accurate International has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Accurate International raised?
Accurate International has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Accurate International last raise money?
Accurate International's most recent round on record is a Series B, in May 2025.
What does Accurate International do?
, Ltd develops and applies organoid technologies for use in cancer precision therapy, new drug development and regenerative medicine.
Where is Accurate International headquartered?
Accurate International is headquartered in Guangzhou, China.
Which VCs invest in companies like Accurate International?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Accurate International's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Accurate International? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.